Remote Monitoring of Hypertension Diseases in Pregnancy: A Pilot Study
- PMID: 28279948
- PMCID: PMC5364324
- DOI: 10.2196/mhealth.6552
Remote Monitoring of Hypertension Diseases in Pregnancy: A Pilot Study
Abstract
Background: Although remote monitoring (RM) has proven its added value in various health care domains, little is known about the remote follow-up of pregnant women diagnosed with a gestational hypertensive disorders (GHD).
Objective: The aim of this study was to evaluate the added value of a remote follow-up program for pregnant women diagnosed with GHD.
Methods: A 1-year retrospective study was performed in the outpatient clinic of a 2nd level prenatal center where pregnant women with GHD received RM or conventional care (CC). Primary study endpoints include number of prenatal visits and admissions to the prenatal observation ward. Secondary outcomes include gestational outcome, mode of delivery, neonatal outcome, and admission to neonatal intensive care (NIC). Differences in continuous and categorical variables in maternal demographics and characteristics were tested using Unpaired Student's two sampled t test or Mann-Whitney U test and the chi-square test. Both a univariate and multivariate analysis were performed for analyzing prenatal follow-up and gestational outcomes. All statistical analyses were done at nominal level, Cronbach alpha=.05.
Results: Of the 166 patients diagnosed with GHD, 53 received RM and 113 CC. After excluding 5 patients in the RM group and 15 in the CC group because of the missing data, 48 patients in RM group and 98 in CC group were taken into final analysis. The RM group had more women diagnosed with gestational hypertension, but less with preeclampsia when compared with CC (81.25% vs 42.86% and 14.58% vs 43.87%). Compared with CC, univariate analysis in RM showed less induction, more spontaneous labors, and less maternal and neonatal hospitalizations (48.98% vs 25.00%; 31.63% vs 60.42%; 74.49% vs 56.25%; and 27.55% vs 10.42%). This was also true in multivariate analysis, except for hospitalizations.
Conclusions: An RM follow-up of women with GHD is a promising tool in the prenatal care. It opens the perspectives to reverse the current evolution of antenatal interventions leading to more interventions and as such to ever increasing medicalized antenatal care.
Keywords: eHealth; gestational hypertension disorders; pregnancy; remote monitoring.
©Dorien Lanssens, Thijs Vandenberk, Christophe JP Smeets, Hélène De Cannière, Geert Molenberghs, Anne Van Moerbeke, Anne van den Hoogen, Tiziana Robijns, Sharona Vonck, Anneleen Staelens, Valerie Storms, Inge M Thijs, Lars Grieten, Wilfried Gyselaers. Originally published in JMIR Mhealth and Uhealth (http://mhealth.jmir.org), 09.03.2017.
Conflict of interest statement
Conflicts of Interest: None declared.
Figures
References
-
- Singh Renu. Hypertensive Disorders in Pregnancy. Clinical Queries: Nephrology. 2013;2:47–55.
-
- Magee LA, Pels A, Helewa M, Rey E, von DP, Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens. 2014 Apr;4(2):105–45. doi: 10.1016/j.preghy.2014.01.003. http://linkinghub.elsevier.com/retrieve/pii/S2210-7789(14)00004-X S2210-7789(14)00004-X - DOI - PubMed
-
- Gudnadóttir TA, Bateman BT, Hernádez-Díaz S, Luque-Fernandez MA, Valdimarsdottir U, Zoega H. Body Mass Index, Smoking and Hypertensive Disorders during Pregnancy: A Population Based Case-Control Study. PLoS One. 2016;11(3):e0152187. doi: 10.1371/journal.pone.0152187. http://dx.plos.org/10.1371/journal.pone.0152187 PONE-D-15-31705 - DOI - PMC - PubMed
-
- van Baaren GJ, Broekhuijsen K, van Pampus MG, Ganzevoort W, Sikkema JM, Woiski MD, Oudijk MA, Bloemenkamp K, Scheepers H, Bremer HA, Rijnders R, van Loon AJ, Perquin D, Sporken J, Papatsonis D, van Huize ME, Vredevoogd CB, Brons J, Kaplan M, van KaaM AH, Groen H, Porath M, van den Berg PP, Mol B, Franssen M, Langenveld J, HYPITAT-II Study Group An economic analysis of immediate delivery and expectant monitoring in women with hypertensive disorders of pregnancy, between 34 and 37 weeks of gestation (HYPITAT-II) BJOG. 2017;124(3):453–61. doi: 10.1111/1471-0528.13957. - DOI - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
